Literature DB >> 10933668

Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae.

T Gottlieb, C Wolfson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933668     DOI: 10.1093/jac/46.2.330

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

Authors:  J M Bell; J D Turnidge; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 2.  Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues.

Authors:  Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

Review 3.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Increased cefepime MIC for enterobacteriacae clinical isolates.

Authors:  Narges Najafi; Ahmad Alikhani; Farhang Babamahmoudi; Alireza Davoudi; Roya Ghasemiyan; Shahriar Aliyan; Arman Shoujaiifar
Journal:  Caspian J Intern Med       Date:  2013

5.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.